PETV's Business Model
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
| Sector & Industry | Healthcare / Medical - Devices |
| Website | https://www.petvivo.com |
| CEO (Chief Executive Officer) | John Lai |
| Number of Employees | |
| IPO date | September 8, 2014 |
PETV Latest News
|
|
|
|
|
|
|
|
|
|
| Contact | |
|---|---|
| Country | US |
| Address | 5251 Edina Industrial Boulevard |
| City | Minneapolis |
| State | MN |
| Phone | 952 405 6216 |
| Zip Code | 55439 |
| Other Identifiers | |
| CIK | 0001512922 |
| ISIN | US7168174081 |
| CUSIP | 716817408 |
| Open | 0.71 |
| Previous Close | 0.748 |
| Volume | 5.14 Thou. |
| Average Volume | 16.71 Thou. |
| Day’s Range | 0.71 – 0.7481 |
| 52 Week Range | 0.45-1.69 |
| MA (50) | 0.9522 |
| MA (200) | 0.96728 |
| Market Cap | 20.28 Mil. |
| Shares Out. | 27.11 Mil. |
| Earnings Date | Jun 25, 2026 |
| Beta | |
| Last Dividend | |
| EPS | |
| PE | |
Industry Competitors for PETV
|
Company
|
PE Ratio | Market Cap |
|---|---|---|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
